These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9261254)

  • 1. Bimodal effects of angiotensin II on migration of human and rat smooth muscle cells. Direct stimulation and indirect inhibition via transforming growth factor-beta 1.
    Liu G; Espinosa E; Oemar BS; Lüscher TF
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1251-7. PubMed ID: 9261254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.
    Stoll M; Steckelings UM; Paul M; Bottari SP; Metzger R; Unger T
    J Clin Invest; 1995 Feb; 95(2):651-7. PubMed ID: 7860748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of angiotensin II and angiotensin II receptors in vascular smooth muscle cell migration in vitro.
    Jing T; He G; Liu J; Wang G; Wu H; Wang H
    Chin Med J (Engl); 2002 May; 115(5):649-53. PubMed ID: 12133528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II-induced progression of neointimal thickening in the balloon-injured rat carotid artery is AT1 receptor mediated.
    van Kleef EM; Fingerle J; Daemen MJ
    Arterioscler Thromb Vasc Biol; 1996 Jul; 16(7):857-63. PubMed ID: 8673560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of a novel angiotensin II type 1 receptor antagonist RNH-6270 on growth of vascular smooth muscle cells from spontaneously hypertensive rats: different anti-proliferative effect to angiotensin-converting enzyme inhibitor.
    Teng J; Fukuda N; Suzuki R; Takagi H; Ikeda Y; Tahira Y; Kanmatsuse K
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):161-71. PubMed ID: 11791001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of BAY 10-6734 (Embusartan), a new angiotensin II type I receptor antagonist, on vascular smooth muscle cell growth.
    Iouzalen L; Stepien O; Marche P
    J Pharmacol Exp Ther; 1999 Apr; 289(1):181-7. PubMed ID: 10087002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II increases proto-oncogene expression and phosphoinositide turnover in vascular smooth muscle cells via the angiotensin II AT1 receptor.
    Lyall F; Dornan ES; McQueen J; Boswell F; Kelly M
    J Hypertens; 1992 Dec; 10(12):1463-9. PubMed ID: 1338078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II receptor blockade during gestation attenuates collagen formation in the developing rat heart.
    Lamparter S; Sun Y; Weber KT
    Cardiovasc Res; 1999 Jul; 43(1):165-72. PubMed ID: 10536701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AT1 receptors mediate the release of prostaglandins in porcine smooth muscle cells and rat astrocytes.
    Leung KH; Chang RS; Lotti VJ; Roscoe WA; Smith RD; Timmermans PB; Chiu AT
    Am J Hypertens; 1992 Sep; 5(9):648-56. PubMed ID: 1418854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HR 720, a novel angiotensin receptor antagonist inhibits the angiotensin II-induced trophic effects, fibronectin release and fibronectin-EIIIA+ expression in rat aortic vascular smooth muscle cells in vitro.
    Dunn FW; Roux MH; Farhadian F; Sabri K; Ossart C; Samuel JL; Rappaport L; Hamon G
    J Pharmacol Exp Ther; 1997 Jan; 280(1):447-53. PubMed ID: 8996227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II.
    Chen K; Mehta JL; Li D; Joseph L; Joseph J
    Circ Res; 2004 Dec; 95(12):1167-73. PubMed ID: 15539634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-beta1 expression in vascular smooth muscle cells.
    Hamaguchi A; Kim S; Izumi Y; Zhan Y; Yamanaka S; Iwao H
    Hypertension; 1999 Jul; 34(1):126-31. PubMed ID: 10406835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EXP3174, a metabolite of losartan (MK 954, DuP 753) is more potent than losartan in blocking the angiotensin II-induced responses in vascular smooth muscle cells.
    Sachinidis A; Ko Y; Weisser P; Meyer zu Brickwedde MK; Düsing R; Christian R; Wieczorek AJ; Vetter H
    J Hypertens; 1993 Feb; 11(2):155-62. PubMed ID: 8385175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR.
    Touyz RM; Endemann D; He G; Li JS; Schiffrin EL
    Hypertension; 1999 Jan; 33(1 Pt 2):366-72. PubMed ID: 9931131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts.
    Kawano H; Cody RJ; Graf K; Goetze S; Kawano Y; Schnee J; Law RE; Hsueh WA
    Hypertension; 2000 Jan; 35(1 Pt 2):273-9. PubMed ID: 10642310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of TH-142177 on angiotensin II-induced proliferation, migration and intracellular signaling in vascular smooth muscle cells and on neointimal thickening after balloon injury.
    Nozawa Y; Matsuura N; Miyake H; Yamada S; Kimura R
    Life Sci; 1999; 64(22):2061-70. PubMed ID: 10374931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
    Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
    Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II and PDGF-BB stimulate beta(1)-integrin-mediated adhesion and spreading in human VSMCs.
    Kappert K; Schmidt G; Doerr G; Wollert-Wulf B; Fleck E; Graf K
    Hypertension; 2000 Jan; 35(1 Pt 2):255-61. PubMed ID: 10642307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of SR 47436, a novel angiotensin II AT1 receptor antagonist, on human vascular smooth muscle cells in vitro.
    Herbert JM; Delisée C; Dol F; Schaeffer P; Cazaubon C; Nisato D; Chatelain P
    Eur J Pharmacol; 1994 Jan; 251(2-3):143-50. PubMed ID: 8149971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
    Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
    J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.